CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Neurovisiondevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00348075
NCT00348075N/ACompleted
CompareCT.gov

A Singapore Study To Evaluate The Efficacy OF Neurovision'S NVC™- Vision Correction Technology For The Visual Improvement In Subjects With Low Or Moderate Adult Myopia

Singapore National Eye Centre·interventional·Posted Jul 4, 2006·Updated May 12, 2010

In Brief

A clinical study evaluating Neurovision for Myopia. Completed, across 1 site.

Detailed Summary

To evaluate the efficacy of NeuroVision NVC vision correction technology to improve the vision of subjects with Low and Moderate Myopia in Asian eyes in Singapore

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesSingapore
CollaboratorsDefence Medical Research Institute, Singapore Armed Forces, NeuroVision

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 4, 2006
Enrollment StartJan 1, 2004
Primary CompletionJan 1, 2009
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 20.0 years ago

Interventions

Neurovisiondevice